Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Cabotamig by Arbele for Gastric Cancer: Likelihood of Approval
Cabotamig is under clinical development by Arbele and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...
Data Insights
Cabotamig by Arbele for Gastrointestinal Tumor: Likelihood of Approval
Cabotamig is under clinical development by Arbele and currently in Phase I for Gastrointestinal Tumor. According to GlobalData, Phase I...